Higher-risk subgroups of COVID-19 patients tend to have lymphopenia accompanied by overall leucocytosis and high levels of inflammatory markers (C-reactive protein [CRP], fibrinogen, ferritin, IL-6) [40]. Here, IL6 is linked to lymphopenia.